Recent news on Denavir

Barrier Gets Canadian Xolegel Approval  -  Mar 8, 2007
Houston Chronicle,The company, which currently sells its Vaniqa, Denavir and Solage dermatology products in Canada, said it expects to launch Xolegel there during the second

Barrier Therapeutics Receives Regulatory Approval to Market ...  -  Mar 8, 2007
Genetic Engineering News (press release),...and look forward to adding the product to our line of currently marketed dermatology products in Canada including VANIQA(R), Denavir(R) and Solage(R)."

Barrier Therapeutics Receives Regulatory Approval to Market ...  -  Mar 8, 2007
Market Wire (press release)...year and look forward to adding the product to our line of currently marketed dermatology products in Canada including VANIQA®, Denavir® and Solagé®."

Pharma Sector - Weekly Wrap-up: Will Merck's Vioxx Heir Arcoxia ...  Aug 25, 2006
...(BTRX | charts | news | PowerRating), a specialty pharmaceutical company focused on dermatology, launched its cold sores medication ' Denavir' in Canada. ... -Trading Markets

Treatment hits herpes with one-day wallop  Aug 26, 2006
...valacyclovir) and Famvir (famciclovir) - followed. An ointment for cold sores, Denavir (penciclovir), is also available. "This class of drugs ... -Bradenton Herald

Barrier Launches Denavir in Canada  Aug 23, 2006
...a pharmaceutical company developing and commercializing products in the field of dermatology, has announced the commercial launch of Denavir in Canada. ... -International News Service

Barrier Therapeutics Announces Launch Of Denavir In Canada - Quick ...  Aug 23, 2006
...(RTTNews) - Wednesday, Barrier Therapeutics Inc. (BTRX | charts | news | PowerRating) revealed the commercial launch of Denavir 1% in Canada. ... -Trading Markets

Barrier Therapeutics Launches Denavir(R) in Canada  Aug 23, 2006
...company developing and commercializing products in the field of dermatology, today announced the commercial launch of Denavir® (penciclovir cream) 1% in Canada ... -Market Wire

Barrier Therapeutics Markets Denavir in Canada  Aug 23, 2006
Pharmaceutical company Barrier Therapeutics (Nasdaq: BTRX) in Princeton says it plans to commercially market Denavir topical antiviral prescription cream in ... -Business New Jersey (subscription)

Barrier Therapeutics Launches Denavir(R) in Canada  Aug 23, 2006
...a pharmaceutical company developing and commercializing products in the field of dermatology, today announced the commercial launch of Denavir(R) (penciclovir ... -Genetic Engineering News

Pharma Sector - Weekly Wrap-up: Will Merck's Vioxx Heir Arcoxia ...  Aug 25, 2006
...(BTRX | charts | news | PowerRating), a specialty pharmaceutical company focused on dermatology, launched its cold sores medication ' Denavir' in Canada. ... -Trading Markets

Treatment hits herpes with one-day wallop  Aug 26, 2006
...valacyclovir) and Famvir (famciclovir) - followed. An ointment for cold sores, Denavir (penciclovir), is also available. "This class of drugs ... -Bradenton Herald

A one-day wallop for treating herpes  Aug 22, 2006
...and Famvir (famciclovir) -- followed. An ointment for cold sores, Denavir (penciclovir), is also available. Over the years, doctors ... -Miami Herald

FDA Approves Supplemental New Drug Application for Antiviral ...  Jul 31, 2006
...is Pregnancy Category B. Famvir is contraindicated in patients with known hypersensitivity to the product, its components, or Denavir® (penciclovir cream). -DG News



Barrier Therapeutics Announces First Quarter 2006 Financial ...  May 2, 2006
Execution of an agreement with Novartis Consumer Health Canada, Inc., under which Barrier will market and distribute Denavir® (penciclovir cream) 1% in ... - Market Wire





Barrier Therapeutics Acquires the Canadian Distribution Rights For ...  Mar 15, 2006
...products in the field of dermatology, today announced that it acquired the exclusive rights to market and distribute Denavir ® (penciclovir cream) 1% in ... - PharmaLive.com

Barrier Therapeutics Purchases Canadian Distribution Rights For ...  Mar 15, 2006
...(RTTNews) - Barrier Therapeutics Inc. (BTRX | charts | news | Powerrating) said it acquired the exclusive rights to market and distribute Denavir 1% in Canada ... - Trading Markets

Barrier to distribute cold sore cream in Canada  Mar 16, 2006
By Staff Writer. Barrier Therapeutics has acquired exclusive rights to market and distribute Novartis' Denavir cold sore treatment in Canada. ... - Pharmaceutical Business Review

Novartis: Strengthening Its Infectious Disease Portfolio  Feb 9, 2006
Currently, Novartis' ID portfolio consists of antivirals, including Famvir (famciclovir) and Denavir (penciclovir), and antifungals, specifically Lamisil ... - International News Service,

Novartis: strengthening its infectious disease portfolio  Feb 7, 2006
Currently, Novartis' ID portfolio consists of antivirals, including Famvir (famciclovir) and Denavir (penciclovir), and antifungals, specifically Lamisil ... - Pharmaceutical Business Review

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional